Evaluation of an individual feedback report on patient-reported outcomes in the Prospective Dutch ColoRectal Cancer cohort

• Published in: Supportive care in cancer 2022-09, Vol.30 (9), p.7303-7312
• Main Authors: Vissers, Pauline A. J., Vink, Geraldine R., Koelink, Maaike R., Koopman, Miriam, Arts, Lindy P. J., Oerlemans, Simone, May, Anne M., van de Poll-Franse, Lonneke V., van Erning, Felice N.
• Format: Article
• Language: English
• Subjects: Analysis; Cancer patients; Cancer therapies; Care and treatment; Clinical outcomes; Colorectal cancer; Data collection; Feedback; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Nursing; Nursing Research; Oncology; Original Article; Pain Medicine; Patient outcomes; Patients; Questionnaires; Rehabilitation Medicine; Response rates
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-022-07165-5

Purpose Returning patient-reported outcomes to patients might aid patients in detecting symptoms and might facilitate early intervention. This descriptive study evaluates the use of an individual feedback report on patient-reported outcomes for colorectal cancer patients and aims to assess differences in patient, tumor, and treatment characteristics and cohort retention between patients who opt and do not opt for the feedback report. Methods Patients with colorectal cancer participating in the nationwide Prospective Dutch ColoRectal Cancer Cohort, who filled in questionnaires digitally between June 2018 and January 2019, were included. Participants were given the option to receive a feedback report at baseline, 3, 6, and 12 months. The usefulness, content, and layout of the feedback report were evaluated. Differences in patient, tumor, and treatment characteristics, patient-reported outcomes, and cohort retention at subsequent questionnaires between participants who did and did not opt for feedback were assessed. Results A total of 484 participants were included of whom 293 (61%) opted for feedback. The feedback report was considered useful by 92%. No differences in patient, tumor, and treatment characteristics, and patient-reported outcomes were found between participants who did and did not opt for feedback. The response rate was higher among patients who opted for feedback compared to patients who did not opt for feedback at T3 (84 vs 74%), but not at T6 and T12. Conclusion The feedback report was used by 6 out of 10 patients. The feedback report was considered valuable and associated with a higher subsequent response rate.